Tianyin Pharmaceutical Co Stock Cash Flow From Operations
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Cash Flow From Operations Analysis
Tianyin Pharmaceutical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Tianyin Pharmaceutical Cash Flow From Operations | (1.25 M) |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Tianyin Pharmaceutical Co has (1.25 Million) in Cash Flow From Operations. This is much lower than that of the sector and significantly lower than that of the Pharmaceutical Products industry. The cash flow from operations for all United States stocks is notably higher than that of the company.
Tianyin Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in cash flow from operations category among its peers.
Tianyin Fundamentals
| Return On Asset | -1.24 | |||
| Profit Margin | (13.72) % | |||
| Operating Margin | (7.06) % | |||
| Current Valuation | (7.22 M) | |||
| Shares Outstanding | 29.43 M | |||
| Shares Owned By Insiders | 26.44 % | |||
| Shares Owned By Institutions | 6.40 % | |||
| Number Of Shares Shorted | 112.52 K | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 0.05 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 29.64 M | |||
| Gross Profit | 15.88 M | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 15.16 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.64 X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 1 K | |||
| Beta | 2.79 | |||
| Total Asset | 101.35 M | |||
| Retained Earnings | 50.19 M | |||
| Working Capital | 23.39 M | |||
| Current Asset | 27.53 M | |||
| Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |